{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:33:20Z","timestamp":1773239600512,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T00:00:00Z","timestamp":1274313600000},"content-version":"vor","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.ejphar.2009.05.009","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T04:58:49Z","timestamp":1242881929000},"page":"50-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Tormentic acid reduces vascular smooth muscle cell proliferation and survival"],"prefix":"10.1016","volume":"615","author":[{"given":"Anelize S.","family":"Fogo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Antonioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o B.","family":"Calixto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre H.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.05.009_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1271\/bbb.68.85","article-title":"Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor promoting effects","volume":"68","author":"Banno","year":"2004","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ejphar.2009.05.009_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-1999-13962","article-title":"Study of the antinociceptive action of the ethanolic extract and the triterpene 24-hydroxytormentic acid isolated from the stem bark of Ocotea suaveolens","volume":"65","author":"Beirith","year":"1999","journal-title":"Planta Med."},{"key":"10.1016\/j.ejphar.2009.05.009_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(02)02428-7","article-title":"Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice","volume":"453","author":"Bortalanza","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.05.009_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/med.10053","article-title":"Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection","volume":"24","author":"Cichewicz","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2009.05.009_bib5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/nm1102-1249","article-title":"Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies","volume":"8","author":"Dzau","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2009.05.009_bib6","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents. Importance of delayed healing","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2009.05.009_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1253\/circj.71.220","article-title":"Impaired endothelial vasomotor function after sirolimus-eluting stent implantation","volume":"71","author":"Fuke","year":"2007","journal-title":"Circ. J."},{"key":"10.1016\/j.ejphar.2009.05.009_bib8","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1248\/cpb.51.1318","article-title":"Antitumor-promoting constituents from Chaenomeles sinensis KOEHNE and their activities in JB6 mouse epidermal cells","volume":"51","author":"Gao","year":"2003","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2009.05.009_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF02980076","article-title":"Antiplatelet pentacyclic triterpenoids from leaves of Campsis grandiflora","volume":"27","author":"Jin","year":"2004","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejphar.2009.05.009_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/14779072.5.3.441","article-title":"Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy","volume":"5","author":"Kakar","year":"2007","journal-title":"Exp. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2009.05.009_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3748\/wjg.v8.i3.493","article-title":"Effects of ursolic acid and oleanolic acid on human colon carcinoma cell line HCT15","volume":"8","author":"Li","year":"2002","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2009.05.009_bib12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.mehy.2007.01.090","article-title":"Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects","volume":"69","author":"Li","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2009.05.009_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0378-8741(95)90032-2","article-title":"Pharmacology of oleanolic acid and ursolic acid","volume":"49","author":"Liu","year":"1995","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2009.05.009_bib14","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.05.009_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0167-4838(02)00227-3","article-title":"Novel anti-inflammatory compounds from Rubus sieboldii, triterpenoids, are inhibitors of mammalian DNA polymerases","volume":"1596","author":"Murakami","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2009.05.009_bib16","first-page":"241","article-title":"Ursolic acid: an anti-tumorigenic and chemopreventive activity","volume":"48","author":"Novotny","year":"2001","journal-title":"Minireview Neoplasma"},{"key":"10.1016\/j.ejphar.2009.05.009_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1152\/physrev.1995.75.3.487","article-title":"Regulation of differentiation of vascular smooth muscle cells","volume":"75","author":"Owens","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2009.05.009_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2005.09.042","article-title":"Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries","volume":"524","author":"Parry","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.05.009_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.RES.79.4.748","article-title":"Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II","volume":"79","author":"Pollman","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2009.05.009_bib20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM198602203140806","article-title":"The pathogenesis of atherosclerosis\u2014an update","volume":"314","author":"Ross","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.05.009_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.05.009_bib22","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/S0002-8703(99)70266-8","article-title":"Atherosclerosis is an inflammatory disease","volume":"138","author":"Ross","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2009.05.009_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/01.RES.58.4.427","article-title":"Replication of smooth muscle cells in vascular disease","volume":"58","author":"Schwartz","year":"1986","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2009.05.009_bib24","first-page":"4375","article-title":"Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1","volume":"63","author":"Shishodia","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2009.05.009_bib25","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1152\/japplphysiol.01114.2004","article-title":"Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype","volume":"98","author":"Stegemann","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2009.05.009_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.05.009_bib27","first-page":"2399","article-title":"Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells","volume":"60","author":"Subbaramaiah","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2009.05.009_bib28","first-page":"717","article-title":"Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages","volume":"58","author":"Suh","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2009.05.009_bib29","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.292.15.1867","article-title":"Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease","volume":"292","author":"Tran","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2009.05.009_bib30","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.297.18.2001","article-title":"Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents","volume":"297","author":"Win","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2009.05.009_bib31","first-page":"266","article-title":"The pathology of heart allograft rejection","volume":"115","author":"Winters","year":"1991","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ejphar.2009.05.009_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.RES.0000155951.62152.2e","article-title":"Molecular determinants of vascular smooth muscle cell diversity","volume":"96","author":"Yoshida","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2009.05.009_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10557-006-0509-4","article-title":"Ursane triterpenoids inhibit atherosclerosis and xanthoma in LDL receptor knockout mice","volume":"20","author":"Zhang","year":"2006","journal-title":"Cardiovasc. Drugs Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909004725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909004725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:09:51Z","timestamp":1757974191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299909004725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":33,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0014299909004725"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.05.009","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tormentic acid reduces vascular smooth muscle cell proliferation and survival","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}